Melrose FutureLab Inflammation Modulator 60 Capsules

Melrose FutureLab Inflammation Modulator 60 Capsules

General Information

Melrose FutureLab Inflammation modulator is a premium quality formula featuring Meriva Curcuma longa phospholipid complex, a patented and clinically trialled form of curcumin, designed to deliver whole-body anti-inflammatory support. Reducing inflammation in the body can support improved quality of life. Levagen+ is a bioavailability-enhanced form of Palmitoylethanolamide (PEA), a fatty acid that belongs to the family of endocannabinoids. It helps to relieve symptoms of mild arthritis and reduces mild joint aches and pains. Our formula leverages both Phytosomal and LipiSperse technologies, active
ingredient delivery systems designed to enhance absorption rates and optimise bioavailability within the body.

Warnings

Adults only. The medicine may interact with other prescription
analgesic medicines, please consult your healthcare practitioner before use.
Not to be used for more than 21 consecutive days. In very rare cases, Curcuma species may harm the liver. Stop use and see a doctor if you have
yellowing skin/eyes or unusual: fatigue, nausea, appetite loss, abdominal pain, dark urine, or itching. If symptoms persist, talk to your health professional.
Store below 250C away from direct sunlight. Do not use if tamper evident seals are broken or missing.

Common Uses

Daily Supplement for whole-body anti-inflammatory support.

Ingredients

Meriva Curcumin Phytosome 500 mg
containing Curcuma longa fresh rhizome extract 100 mg
derived from Curcuma longa fresh rhizome min 16.5 g
std. to contain curcuminoids 90 mg
Levagen+ LipiSperse Palmidrol (PEA) 300 mg

Directions

Adults - Take two capsule with water, daily, or as directed
by your health professional